Dr. Jimmy Lin,MD, PhD, Founder of Rare Genomics Institute.
MEBO Research is proud to have Dr. Jimmy Lin as a member of the MEBO Research Institutional Review Board (IRB). One of Hacking Work's 100 Disruptive Heroes: Jimmy Lin is Founder of Rare Genomics Institute (RGI), empowering communities and accelerating research. RGI is a non-profit biotech venture that micro funds and enables genome sequencing for children with rare diseases. The Mission of RareGenomics is dedication to overcoming barriers, a culture of caring, focused on the individual, organizational transparency, and tangible results.
As noted in the RGI website,
To Our Patients
We will provide superior patient care, and do our best in everything to support our patients. We are patient-champions, fighting for the causes for those who have long been neglected by society.
To Our Donors
We promise to use all donated funds for the sole purpose of supporting our patients. We will be transparent in organizational processes so as to be worthy of the trust we gain from our donors.
Jimmy is the lead computational biologist for the ground-breaking cancer genome sequencing efforts from the Vogelstein Lab at Johns Hopkins. Their sequencing of the first 100+ cancer exomes in 5 different tissue types has helped lay the foundation for a revolution in cancer genomics.
We are most grateful for Jimmy's membership and participation in the MEBO IRB, and look forward to a long and fruitful relationship with him and his organization.
María de la Torre
Founder and Executive Director
A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)
0 comments: